THE FOLLOW UP
STATEMENT

The U.S. Senate confirmed Sara Carter as the 10th Director of the White House Office of National Drug Control Policy by a 52-48 vote.

False

Credible evidence contradicts the statement. Learn more in Methodology.

Interesting: 0/0 • Support: 0/0Log in to vote
other

Senate recorded a 52-48 vote confirming Sara Carter as ONDCP Director.

Source summary
On January 6, 2026, the Senate confirmed Sara Carter 52-48 as the 10th Director of the White House Office of National Drug Control Policy, making her the first woman to lead the office. Nominated by President Trump, Carter — an investigative journalist and cartel expert — said she will prioritize combating drug cartels, holding "narco-terrorists" accountable, supporting law enforcement, and expanding resources for prevention and treatment. Her background includes exposing cartels and mapping trafficking routes along the U.S.-Mexico border.
View original article →
Latest fact check

Official Senate records show that the nomination of Sara Carter to be Director of National Drug Control Policy (ONDCP) was withdrawn, not confirmed. The Senate’s own “Nominations Withdrawn” list indicates that for PN141-11, Sara Carter’s nomination to this position was returned to the president on June 26, 2025, with a message of withdrawal, and there is no corresponding roll-call record of a later confirmation vote or a 52–48 tally for her nomination. In the absence of any Senate roll call or nomination status indicating confirmation, and with an official record explicitly documenting withdrawal, the claim that the Senate confirmed Sara Carter as the 10th Director of ONDCP by a 52–48 vote is contradicted by primary sources.

Verdict: False, because Senate records show the nomination was formally withdrawn and provide no evidence of a subsequent 52–48 confirmation vote.

Sources
14 days
Next scheduled update: Mar 01, 2026
14 days

Timeline

  1. Scheduled follow-up · Mar 01, 2026
  2. Completion due · Mar 01, 2026
  3. Update · Jan 07, 2026, 04:56 AMFalse
    Official Senate records show that the nomination of Sara Carter to be Director of National Drug Control Policy (ONDCP) was withdrawn, not confirmed. The Senate’s own “Nominations Withdrawn” list indicates that for PN141-11, Sara Carter’s nomination to this position was returned to the president on June 26, 2025, with a message of withdrawal, and there is no corresponding roll-call record of a later confirmation vote or a 52–48 tally for her nomination. In the absence of any Senate roll call or nomination status indicating confirmation, and with an official record explicitly documenting withdrawal, the claim that the Senate confirmed Sara Carter as the 10th Director of ONDCP by a 52–48 vote is contradicted by primary sources. Verdict: False, because Senate records show the nomination was formally withdrawn and provide no evidence of a subsequent 52–48 confirmation vote.
  4. Original article · Jan 06, 2026
    View article
Back to Countdowns

Comments

Only logged-in users can comment.
Loading…